Epstein Secrets

s had agreed to a White House demand that $1.75 billion for a new F.B.I. building be tucked into their emergency coronavirus relief bill," and Sen. Richard Shelby (R-AL) "the chairman of the Appropriations Committee, framed the item as a Trump administration priority, not a Republican one. Other Republicans we

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

ns had agreed to a White House demand that $1.75 billion for a new F.B.I. building be tucked into their emergency coronavirus relief bill," and Sen. Richard Shelby (R-AL) "the chairman of the Appropriations Committee, framed the item as a Trump administration priority, not a Republican one. Other Republicans w

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." UN

s had agreed to a White House demand that $1.75 billion for a new F.B.I. building be tucked into their emergency coronavirus relief bill," and Sen. Richard Shelby (R-AL) "the chairman of the Appropriations Committee, framed the item as a Trump administration priority, not a Republican one. Other Republicans we

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U

s had agreed to a White House demand that $1.75 billion for a new F.B.I. building be tucked into their emergency coronavirus relief bill," and Sen. Richard Shelby (R-AL) "the chairman of the Appropriations Committee, framed the item as a Trump administration priority, not a Republican one. Other Republicans we

by Pfizer and German biotech BioNTech SE to inoculate 50 million people at a price of $39 for a two-dose treatment course." Pfizer Chief Executive Albert Bourla is quoted as saying, "All the countries that are developed right now will not receive a lower price for the same volume commitment than the US." U